Seroprevalence of West Nile virus in Khuzestan province, southwestern Iran, 2016–2017
Autor: | Shokrollah Salmanzadeh, Vahid Baniasadi, Mostafa Salehi-Vaziri, Mohammad Hassan Pouriayevali, Morteza Kharat, Mehdi Fazlalipour, Masoumeh Kalantari |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Adult
Male Adolescent Cross-sectional study West Nile virus viruses Population Enzyme-Linked Immunosorbent Assay Iran Biology Antibodies Viral medicine.disease_cause Disease Outbreaks lcsh:Infectious and parasitic diseases Young Adult Seroepidemiologic Studies Environmental health medicine Humans Seroprevalence lcsh:RC109-216 Antiviral treatment Child education Aged education.field_of_study Age Factors Outbreak virus diseases General Medicine Middle Aged biology.organism_classification nervous system diseases Flavivirus Cross-Sectional Studies Infectious Diseases Immunoglobulin G Female Parasitology West Nile Fever |
Zdroj: | Journal of Vector Borne Diseases, Vol 56, Iss 3, Pp 263-267 (2019) |
ISSN: | 0972-9062 |
Popis: | Background & objectives: West Nile virus (WNV) is a neurotropic Flavivirus transmitted to humans through mosquito bites. As there is no specific antiviral treatment or approved vaccine against WNV, control and prevention of the infection is the best strategy to reduce the burden of WNV-related diseases. The circulation of WNV has been indicated in several regions of Iran including the Khuzestan province. Considering the complex ecology of WNV, the latest data are necessary for the implementation of preventive measures. Therefore, the present study was designed to provide updated information on the seroepidemiology of WNV in Khuzestan province. Methods: A total of 408 sera were taken from volunteers living in Khuzestan. The presence of specific immunoglobulin G (IgG) antibody against WNV was tested by the enzyme-linked immunosorbent assay (ELISA) method. All the data and participants’ demographic information were analyzed by SPSS and Esri’s ArcMap GIS software programs. Results: Anti-WNV IgG antibody was detected in 97 (23.8%) out of the 408 tested sera. The highest seropositivity rate was observed in cases aged between 20–29 yr and the lowest seropositivity rate was seen in those |
Databáze: | OpenAIRE |
Externí odkaz: |